Placebo is a sterile solution in a single use prefilled syringe (PFS) intended for subcutaneous administration, Sonelokimab clinical trials

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of subcutaneous sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (M1095-HS-302)

This study is testing a new medicine, sonelokimab, for adults with moderate to severe hidradenitis suppurativa (HS). It compares the new medicine to a dummy treatment (placebo) to see if it's safe and helps improve HS over 16 weeks.